77846-07-2

Basic information

• Product Name: 2-[(benzyloxy)imino]-acetyl chloride
• Synonyms: 2-[(benzyloxy)imino]-acetyl chloride
• CAS NO: 77846-07-2
• Molecular Weight: 197.621
• Mol File: 77846-07-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2-[(benzyloxy)imino]-acetyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[(benzyloxy)imino]-acetyl chloride(77846-07-2)
• EPA Substance Registry System: 2-[(benzyloxy)imino]-acetyl chloride(77846-07-2)

Safety Data

• Hazardous Substances Data: 77846-07-2(Hazardous Substances Data)

Upstream product

• 2687-43-6 O-benzylhydoxylamine hydrochloride 
• 77845-97-7 2-[(phenylmethoxy)imino]-acetic acid 

Downstream Products

• 77846-09-4 [Benzyloxy-(2-benzyloxyimino-acetyl)-amino]-acetic acid 4-nitro-phenyl ester 
• 77846-11-8 2-[Benzyloxy-(2-benzyloxyimino-acetyl)-amino]-propionic acid 4-nitro-phenyl ester 
• 77846-13-0 2-[Benzyloxy-(2-benzyloxyimino-acetyl)-amino]-3-methyl-butyric acid 4-nitro-phenyl ester 
• 77846-19-6 2-[Benzyloxy-(2-benzyloxyamino-acetyl)-amino]-3-methyl-butyric acid 4-nitro-phenyl ester; hydrochloride 
• 77846-17-4 2-[Benzyloxy-(2-benzyloxyamino-acetyl)-amino]-propionic acid 4-nitro-phenyl ester; hydrochloride 
• 77846-15-2 [Benzyloxy-(2-benzyloxyamino-acetyl)-amino]-acetic acid 4-nitro-phenyl ester; hydrochloride 
• 77846-25-4 1,4-Bis-benzyloxy-3-isopropyl-piperazine-2,5-dione 
• 77846-22-1 1,4-Bis-benzyloxy-3-methyl-piperazine-2,5-dione 
• 77846-21-0 1,4-Bis-benzyloxy-piperazine-2,5-dione 
• 181826-47-1 (3aS,6R,7aR)-1,4,5,7,7a-hexahydro-8,8-dimethyl-1-[(2S)-1-oxo-2-[(phenylmethoxy)amino]-4-pentenyl]-3H-3a,6-methano-2,1-benzisothiazole 2,2-dioxide 
• 948854-84-0 C₁₈H₁₆N₂O₄ 
• 875610-20-1 [(1S,5R,7R)-10,10-Dimethyl-2-oxo-3-(toluene-4-sulfonyl)-3,4-diaza-tricyclo[5.2.1.0^1,5]dec-4-yl]-oxo-acetaldehyde O-benzyl-oxime 
• 875610-18-7 C₂₅H₂₇N₃O₃ 

Relevant articles and documents

COMPOUNDS FOR TREATMENT OF GLIOBLASTOMA

The present invention relates to compounds and methods for the treatment of glioblastoma, as well as to a pharmaceutical composition comprising said compounds. More specifically the invention relates to substituted quinoline derivatives having the formula (I), (II) or (III), and a pharmaceutical composition comprising said compounds for the treatment of cancer. (Formulae (I), (II), (III))

On the scope of diastereoselective allylation of various chiral glyoxylic oxime ethers with allyltributylstannane in the presence of?a Lewis acid and triallylaluminum

The nucleophilic allylation of various chiral auxiliaries derived glyoxylic oxime ethers was studied. The use of allyltributylstannane in the presence of a Lewis acid and triallylaluminum provided the corresponding homoallylic amines in high chemical yiel